Accepted at 2:03 a.m. Nov, 01, 2023 by Ahmed7
Author: rshah050
Related Note: 1477447248845 1
Rationale for change

Exophthalmos and myxedema, specifically pretibial mixedema are NOT symptoms of hypothyroidism but rather Graves disease,

That being said, I can find no source that says Propranaolol would not help in Graves, I am unclear why that last line is in here at all -- all I can say is exophthalmos and "myxedema" are not symptoms of hypothyroidism as the card originally said. Perhaps someone more qualified can decide if that line should be removed entirely.

Source: FA 2023: Page 346 and 348

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step2_v12::#FirstAid::03_Endocrinology::02_Thyroid_Disorders::02_Hyperthyroidism_and_Thyrotoxicosis #AK_Step1_v12::#Physeo::09_Pharm::16_Autonomic_Pharm::06_Beta_Blockers #AK_Step1_v12::#B&B::09_Endocrinology::01_Thyroid::03_Hyperthyroidism #AK_Step1_v12::#OME::04_Organ_Systems::06_Endocrine::03_Thyroid::02_The_Unhealthy_Thyroid_Functional_Disorders #AK_Step2_v12::#UWorld::COMLEX::101912 #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step2_v12::#SketchyIM::05_Endocrinology::06_Retired_Lessons::02_Thyroid_Disease::02_Hyperthyroidism_SOAP_[OLD_VERSION] #AK_Step2_v12::#CMS::EM::Form_01 #PANCE::ENDO::thyroid_disorders #AK_Step1_v12::#SketchyPharm::01_Autonomic_Drugs::02_Sympathetic::04_Beta_blockers #AK_Step2_v12::#B&B::02_Cardio::05_Pharm::01_Cardiovascular_Pharmacology_I #AK_Step1_v12::#AMBOSS::cXaaCQ #AK_Step2_v12::#B&B::02_Cardio::01_Arrhythmias::03_Atrial_Fibrillation_and_Flutter::Extra #PANCE::EOR::PEDS #AK_Step1_v12::#UWorld::Step::6797 #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::06_Retired_Lessons::04_Propylthiouracil,_methimazole,_levothyroxine_[Retired_Video] #AK_Step2_v12::#SketchyIM::05_Endocrinology::02_Thyroid_Disease::02_Hyperthyroidism_SOAP #AK_Step2_v12::#CMS::EM::Form_02 #AK_Step1_v12::#Bootcamp::Pharmacology::03_Autonomic_System::16_Beta_Adrenergic_Antagonists #AK_Step1_v12::#Pixorize::03_Pharmacology::24_Alpha_&_Beta_Blockers_(New)::08_Clinical_Use_of_Beta_Blockers #AK_Step2_v12::#B&B::04_Endocrinology::01_Thyroid_Gland::03_Hyperthyroidism #PANCE::EOR::Surgery #AK_Step1_v12::#UWorld::COMLEX::25259 #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::15_beta-blockers::*B-Antagonists::Nonselective_B_Antagonists::Propranolol #AK_Step1_v12::#OME::PreClinical::04_Organ_Systems::06_Endocrine::03_Thyroid::02_The_Unhealthy_Thyroid_Functional_Disorders #AK_Step1_v12::#Physeo::11_Pathology::02_Endocrine_Pathology::03_Hypothyroidism #AK_Step1_v12::#B&B::09_Endocrinology::01_Thyroid::02_Thyroid_Hormone_Synthesis_&_Labs::Extra #AK_Step2_v12::#AMBOSS::w9ahp5 #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step2_v12::#UWorld::Step::10958 #AK_Step2_v12::#AMBOSS #PANCE::EOR::IM #AK_Step3_v12::#UWorld::5046 #AK_Step1_v12::#Physeo::11_Pathology::02_Endocrine_Pathology::02_Hyperthyroidism #AK_Step1_v12::#Bootcamp::Endocrinology::04_Thyroid::04_Hyperthyroidism:_Graves_Disease